The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Perspectives and attitudes toward the integration of oncology and palliative care in Japan: Qualitative analysis of a nationwide survey.
 
Yu Uneno
No Relationships to Disclose
 
Mayumi Nishimura
No Relationships to Disclose
 
Satoko Ito
No Relationships to Disclose
 
Tatsuya Morita
No Relationships to Disclose
 
Kazuki Sato
No Relationships to Disclose
 
Masanori Mori
No Relationships to Disclose
 
Chikako Shimizu
Honoraria - AstraZeneca; Asuka Seiyaku; Chugai Pharma; Kyowa Hakko Kirin; Taiho Pharmaceutical
Consulting or Advisory Role - AstraZeneca; Eisai; Lilly Japan; Pfizer
Research Funding - Chugai Pharma; Lilly; MSD; Pfizer
 
Yoshiki Horie
No Relationships to Disclose
 
Mami Hirakawa
No Relationships to Disclose
 
Takako Eguchi Nakajima
Honoraria - Bayer; Bristol-Myers Squibb Japan; Chugai Pharma; Dainippon Sumitomo Pharma; Kyowa Hakko Kirin; Lilly Japan; Maruho; MERCK SERONO; MSD; Ono Pharmaceutical; Sanofi; Sawai Pharmaceutical Co; Taiho Pharmaceutical; Takeda
Consulting or Advisory Role - Taiho Pharmaceutical
Research Funding - A2 Healthcare; AstraZeneca; Chugai Pharma; Daiichi Sankyo; Dainippon Sumitomo Pharma; Eisai; Merck Serono; MSD K.K; Ono Pharmaceutical; Sanofi; Taiho Pharmaceutical; Takeda; Yakult Honsha
 
Satoru Tsuneto
No Relationships to Disclose
 
Manabu Muto
Consulting or Advisory Role - Eisai; Kewpie
Research Funding - Chugai Pharma; Mitsui Knowledge Industry; Olympus; Pfizer; Taiho Pharmaceutical; Theravalues Corporation